Ipamorelin + CJC-1295: The Most Popular Peptide Stack Explained

Ipamorelin CJC-1295 has become the most prescribed and widely discussed peptide stack in functional and longevity medicine — and for good reason. Together, these two peptides work synergistically to naturally amplify the body's own growth hormone production, producing meaningful improvements in body composition, recovery, sleep quality, and overall well-being. Unlike synthetic HGH injections, this combination works with your body's natural hormonal rhythms rather than overriding them. Here's the full breakdown.

What Is Ipamorelin?

Ipamorelin is a growth hormone-releasing peptide (GHRP) — specifically, a pentapeptide (composed of five amino acids) that was developed as a selective growth hormone secretagogue. Its primary action is to stimulate the pituitary gland to release a pulse of growth hormone (GH). What distinguishes ipamorelin from older GHRPs like GHRP-2 or GHRP-6 is its selectivity: it stimulates GH release with minimal effect on cortisol, prolactin, or appetite hormones — side effects that are more pronounced with its predecessors.

Ipamorelin mimics ghrelin (the "hunger hormone") by binding to the ghrelin receptor (GHS-R1a) on the pituitary, triggering a GH pulse. But unlike ghrelin itself, ipamorelin is highly selective and doesn't significantly stimulate appetite at therapeutic doses — an important distinction for people using it for body composition goals.

Because ipamorelin stimulates GH in a pulsatile manner that mirrors the body's natural pattern, rather than flooding the system continuously, it preserves the body's own feedback regulation mechanisms. The pituitary continues to respond normally to negative feedback — meaning the body doesn't simply shut down its own GH production in response to the peptide.

What Is CJC-1295?

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) — the hypothalamic hormone that signals the pituitary to produce and release growth hormone. Natural GHRH has a very short half-life (just a few minutes) because enzymes rapidly break it down. CJC-1295 is engineered to resist this enzymatic degradation, dramatically extending its half-life and duration of action.

There are two versions of CJC-1295:

• CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF): Has a half-life of approximately 30 minutes. When used with ipamorelin, it produces a discrete, pulsatile GH release that closely mimics natural GH patterns. This is the form most commonly used in clinical peptide protocols.
• CJC-1295 with DAC (Drug Affinity Complex): Has an extended half-life of 6–8 days due to albumin binding, allowing once or twice weekly dosing. This produces a more sustained elevation of GH rather than pulsatile release, which changes the pharmacological profile significantly.

In most therapeutic protocols, CJC-1295 without DAC is preferred when paired with ipamorelin, as the pulsatile pattern better mimics the body's natural GH rhythm.

How Ipamorelin and CJC-1295 Work Synergistically

Understanding how these two peptides work together requires understanding the two-signal system that controls growth hormone release. The pituitary doesn't release GH in response to a single signal — it requires both:

1. A GHRH signal (from the hypothalamus or, in this case, CJC-1295) — which primes and amplifies the pituitary's responsiveness and stimulates GH synthesis
2. A GHS/ghrelin signal (from ipamorelin) — which triggers the actual GH release event

When both signals arrive at the pituitary simultaneously, the GH release is dramatically greater than either signal alone would produce — a synergistic amplification estimated to produce 2 to 10 times more GH than either peptide used individually. This is why the combination is so powerful and why it's become the standard approach in peptide therapy.

The result is a robust, physiologically patterned growth hormone pulse that elevates IGF-1 (insulin-like growth factor 1) over time — the downstream mediator responsible for most of GH's tissue-building, fat-burning, and repair effects.

Benefits of the Ipamorelin + CJC-1295 Stack

Fat Loss — Especially Visceral Fat

Growth hormone is a potent lipolytic (fat-burning) hormone. It directly stimulates the breakdown of fat stored in adipose tissue, particularly visceral fat (the metabolically active fat stored around abdominal organs). As GH levels naturally decline with age — a process called somatopause — visceral fat accumulation accelerates. Restoring more youthful GH levels via peptide therapy helps reverse this trend.

Most patients notice initial fat loss around the abdomen, often accompanied by improved waist circumference and body composition measurements. This tends to be a gradual process — don't expect dramatic overnight results — but it's consistent and sustained over the course of a multi-month protocol.

Muscle Preservation and Lean Mass

GH and IGF-1 have anabolic effects on skeletal muscle — stimulating protein synthesis and supporting the maintenance or growth of lean muscle tissue. This is particularly relevant for older adults experiencing age-related muscle loss (sarcopenia), athletes seeking improved recovery and adaptation to training, or anyone pursuing body recomposition (losing fat while preserving or building muscle).

Importantly, the peptide stack is not a substitute for resistance training — its anabolic effects are most pronounced when paired with adequate exercise and protein intake. Think of it as enhancing your body's ability to respond to the training stimulus.

Sleep Quality and Deep Sleep Enhancement

Natural GH secretion is heavily concentrated during slow-wave (deep) sleep — particularly in the first few hours of the night. GH is critical for the cellular repair and regeneration that occurs during sleep. Many patients report one of the earliest and most noticeable benefits of ipamorelin/CJC-1295 is dramatically improved sleep quality — deeper, more restorative sleep, fewer nighttime awakenings, and waking feeling genuinely rested.

This makes bedtime the most important injection time (see dosing section below). The pre-sleep injection synchronizes with and amplifies the body's natural nocturnal GH pulse.

Recovery from Exercise and Injury

GH and IGF-1 are central to tissue repair — stimulating collagen synthesis in tendons and ligaments, accelerating muscle fiber repair after exercise, and promoting healing of injured tissues. Athletes and active individuals often report faster recovery between training sessions, reduced muscle soreness, and improved healing of nagging injuries. This is part of why peptide therapy has gained popularity in sports medicine and physical rehabilitation contexts.

Skin, Hair, and Connective Tissue

GH plays a role in maintaining skin elasticity, collagen density, and connective tissue integrity — all of which decline with age. Many patients on extended peptide protocols report improvements in skin thickness and texture, stronger nails, and improved hair quality, though these tend to be secondary to the body composition and recovery benefits for most users.

Energy and Cognitive Function

Suboptimal GH levels are associated with fatigue, reduced motivation, and cognitive sluggishness — symptoms that are often attributed to aging but may partly reflect declining growth hormone. Patients on ipamorelin/CJC-1295 frequently report improved daytime energy, better mental clarity, and a general sense of well-being that they often describe as feeling "younger."

Dosing Protocols

Standard ipamorelin/CJC-1295 dosing protocols vary somewhat between providers, but the general framework is:

Common Dosing Range

• Ipamorelin: 100–300 mcg per injection
• CJC-1295 (without DAC): 100–200 mcg per injection
• Both peptides are typically combined in a single injection (mixed in the same syringe)

Injection Frequency

Frequency depends on goals and tolerance:

• Once daily (bedtime): Minimum effective protocol; prioritizes sleep/recovery benefits
• Twice daily (morning + bedtime): More robust body composition effects; morning injection should be on an empty stomach or at least 2 hours after eating
• Three times daily: Used by some providers for aggressive body composition goals or significant GH deficiency; requires provider supervision

Injection Timing Principles

• Bedtime injection: Most important; amplifies the natural overnight GH pulse. Inject 30–60 minutes before sleep.
• Morning injection: Take on an empty stomach or before eating. Insulin blunts GH release, so injecting when blood sugar is low maximizes the GH pulse.
• Post-workout injection: Some protocols include an injection 30–60 minutes after training to capitalize on exercise-induced GH sensitivity

Cycle Length

Most protocols run 3–6 months, sometimes followed by a 1–2 month break period to allow the pituitary to reset before resuming. Some patients use ongoing maintenance protocols under provider supervision. Your Truventa Medical provider will recommend a cycle structure appropriate for your goals and baseline health.

Administration: How These Peptides Are Injected

Both ipamorelin and CJC-1295 are administered via subcutaneous injection — typically into the abdomen, similar to semaglutide or insulin. The peptides usually come in lyophilized (freeze-dried) powder form in vials that are reconstituted with bacteriostatic water before use. Injection volumes are small (typically 0.1–0.3 mL) using an insulin-type syringe with a very fine needle.

The injections are generally very well-tolerated — significantly less painful than typical intramuscular injections due to the fine needle and small volume. Injection site rotation is recommended, and the technique is quickly learned with proper guidance from your provider.

Side Effects and Safety Considerations

Ipamorelin + CJC-1295 has a favorable safety profile relative to exogenous synthetic HGH, primarily because it works through the body's own regulatory systems:

• Injection site reactions: Mild redness, itching, or transient bumps at the injection site — common and usually resolve within minutes to hours
• Water retention: Some patients experience mild fluid retention in the first few weeks of treatment as IGF-1 levels rise; this typically resolves
• Fatigue or "GH flush": A brief period of drowsiness or warmth shortly after injection — common with the bedtime dose and generally considered benign
• Tingling or numbness: Rare, typically transient, and associated with very high doses
• Cortisol and prolactin: Unlike older GHRPs, ipamorelin has minimal effect on cortisol or prolactin — a significant advantage

Because these peptides stimulate natural GH release rather than replacing it, the risk of oversupression of the pituitary-GH axis is low. Nevertheless, periodic monitoring of IGF-1 levels is recommended to ensure GH/IGF-1 remains in a physiological range.

Who Is a Candidate for Ipamorelin + CJC-1295?

This peptide stack is most appropriate for:

• Adults over 30 experiencing age-related decline in GH levels (somatopause)
• Adults with documented low IGF-1 levels
• Active individuals seeking improved body composition, recovery, and performance
• People with poor sleep quality or recovery despite good sleep habits
• Those interested in longevity-oriented, evidence-guided preventive medicine

The stack is not appropriate for individuals with active malignancy (GH may stimulate tumor growth), pregnant or breastfeeding individuals, those with uncontrolled diabetes, or those with certain pituitary conditions. A thorough evaluation by a licensed provider determines candidacy.

Truventa Medical's Peptide Program

At Truventa Medical, our peptide protocols are designed by experienced providers who specialize in functional and longevity medicine. We begin with a comprehensive online evaluation and, where appropriate, baseline lab work to assess IGF-1, metabolic health, and hormone status. Peptides are sourced from licensed compounding pharmacies and shipped directly to your door.

Our providers are available throughout your protocol for questions, dose adjustments, and follow-up — ensuring you get the most out of your treatment safely and effectively.